In addition, our results also show that the combination therapy significantly decreased the expression of 15-LOX-1, which is a critical enzyme in the formation of lipid peroxidation, inducing inflammation and contributing to delayed tPA-related hemorrhagic transformation after ischemic stroke (32, 34). This evidence concerns the gene PLAT and ischemic stroke.